SEC Form 4 · accession 0001104659-15-032480
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah O. Kalil
Officer — Chief Operating Officer
Period of report
Aug 12, 2014
Accepted (ET)
Apr 30, 2015 · 3:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | Aug 12, 2014 | P | 5,000 | $11.00 | A | 5,000 | I | By Spouse |
| Common Stock, par value $0.001 | holding | — | — | — | 56,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.